Is MCET or NOBL a better dividend investment in 2026?

MCET currently yields 20000000.00% with a 5% 5-year dividend growth rate. NOBL yields 2.17% with 5% growth. The better choice depends on your goal: MCET offers higher current income.

What is the dividend yield difference between MCET and NOBL?

MCET has a forward dividend yield of 20000000.00% ($2.00/share annually). NOBL yields 2.17% ($2.27/share annually). The yield gap is 19999997.83 percentage points.

Home › Compare › MCET vs NOBL

MCET vs NOBL: Dividend Comparison 2026

MCET yields 20000000.00% · NOBL yields 2.17%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MCET wins by $4.875981653489057e+49M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MCET

● Live price

20000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.875981653489057e+49M

Annual income

$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00

Full MCET calculator →

NOBL

● Live price

2.17%

Share price

$104.67

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.9K

Annual income

$249.78

Full NOBL calculator →

Portfolio growth — MCET vs NOBL

📍 MCET pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MCET	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MCET + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MCET pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCET

Annual income on $10K today (after 15% tax)

$1,700,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

NOBL

Annual income on $10K today (after 15% tax)

$184.52/yr

After 10yr DRIP, annual income (after tax)

$212.31/yr

At 15% tax rate, MCET beats the other by $41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCET + NOBL for your $10,000?

MCET: 50%NOBL: 50%

100% NOBL50/50100% MCET

Portfolio after 10yr

$2.4379908267445285e+49M

Annual income

$24,379,668,474,955,630,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

100.00%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCET buys

NOBL buys

No recent congressional trades found for MCET or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMCETNOBL

Forward yield	20000000.00% ✓	2.17%
Annual dividend / share	$2.00	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.875981653489057e+49M	$22.9K ✓
Annual income after 10y	$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓	$249.78
Total dividends collected	$4.875978515990276e+49M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MCET vs NOBL ($10,000, DRIP)

Year	MCET Portfolio	MCET Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$2,000,010,700	$2,000,000,000.00	$10,917	$217.08	+$2000.00M → MCET
2	$373,835,915,712,384	$373,833,775,700,934.50	$11,903	$221.48	+$373835915.70M → MCET
3	$65,304,953,364,964,970,000	$65,304,553,360,535,160,000.00	$12,962	$225.68	+$65304953364964.95M → MCET
4	$10,661,728,832,755,500,000,000,000	$10,661,658,956,455,399,000,000,000.00	$14,099	$229.68	+$10661728832755499008.00M → MCET
5	$1,626,767,783,781,495,000,000,000,000,000	$1,626,756,375,731,643,800,000,000,000,000.00	$15,319	$233.49	+$1.626767783781495e+24M → MCET
6	$231,974,330,054,625,100,000,000,000,000,000,000	$231,972,589,413,096,470,000,000,000,000,000,000.00	$16,628	$237.10	+$2.319743300546251e+29M → MCET
7	$30,915,106,403,922,057,000,000,000,000,000,000,000,000	$30,914,858,191,388,900,000,000,000,000,000,000,000,000.00	$18,033	$240.53	+$3.0915106403922057e+34M → MCET
8	$3,850,507,985,839,278,000,000,000,000,000,000,000,000,000,000	$3,850,474,906,675,425,000,000,000,000,000,000,000,000,000,000.00	$19,539	$243.78	+$3.8505079858392777e+39M → MCET
9	$448,210,261,035,314,200,000,000,000,000,000,000,000,000,000,000,000	$448,206,140,991,769,400,000,000,000,000,000,000,000,000,000,000,000.00	$21,154	$246.86	+$4.4821026103531426e+44M → MCET
10	$48,759,816,534,890,570,000,000,000,000,000,000,000,000,000,000,000,000,000	$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00	$22,884	$249.78	+$4.875981653489057e+49M → MCET

MCET vs NOBL: Complete Analysis 2026

MCET — Stock

MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.

Full MCET Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this MCET vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCET vs SCHD MCET vs JEPI MCET vs O MCET vs KO MCET vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.